DexCom, Inc. (DXCM) — Analyst outlook / Analyst consensus target is. Based on 52 analyst ratings, the consensus is bullish — 1 Strong Buy, 41 Buy, 8 Hold, 2 Sell.
The consensus price target is $85.82 (low: $72.00, high: $95.00), representing an upside of 36.3% from the current price $62.95.
Analysts estimate Earnings Per Share (EPS) of $1.67 and revenue of $4.03B for the next fiscal year.
Earnings Per Share (EPS) track record: 2024: actual $1.46 vs est $1.67 (missed -12.5%). 2025: actual $2.14 vs est $2.06 (beat +3.9%). Analyst accuracy: 91%.
DXCM Stock — 12-Month Price Forecast
$85.82
▲ +36.33% Upside
Average Price Target
Based on 52 Wall Street analysts offering 12-month price targets for DexCom, Inc., the average price target is $85.82, with a high forecast of $95.00, and a low forecast of $72.00.
The average price target represents a +36.33% change from the last price of $62.95.
Highest Price Target
$95.00
Average Price Target
$85.82
Lowest Price Target
$72.00
DXCM Analyst Ratings
Buy
Based on 52 analysts giving stock ratings to DexCom, Inc. in the past 3 months
EPS Estimates — DXCM
91%
Analyst Accuracy
Accurate
2 years compared
Actual vs Estimate
2024
Actual $1.46
vs Est $1.67
▼ 14.3% off
2025
Actual $2.14
vs Est $2.06
▲ 3.7% off
Profitability Outlook
Company is profitable with solid earnings. EPS trend is improving.
Revenue Estimates — DXCM
100%
Analyst Accuracy
Accurate
2 years compared
Actual vs Estimate
2024
Actual $4.033B
vs Est $4.031B
▲ 0.1% off
2025
Actual $4.662B
vs Est $4.652B
▲ 0.2% off
Revenue Trend
Moderate revenue growth trend. Analysts forecast revenue contraction ahead.
